多电极切换系统射频消融治疗不可切除中大型肝细胞癌结节的长期随访
这项前瞻性研究评估多电极切换系统射频消融治疗不可切除3.1-6.0 cm肝细胞癌结节的安全性和有效性,25例肝硬化患者共26个结节接受25次治疗,完全消融率100%,中位随访30个月局部肿瘤进展率19.2%,4年总生存率49%,无操作相关死亡或严重并发症。
要点
- 3.1-4.0 cm肿瘤连续放置2根电极,4.1-5.9 cm放置3根电极,间距2.0-2.5 cm。
- 阻抗升至基线以上30 Ω时功率自动切换至下一电极。
- 消融后30-40天通过CT或MRI评估疗效,完全消融率100%。
核心结论
- 多电极切换系统射频消融可能是治疗3.1-6.0 cm不可切除肝细胞癌肿瘤的一种安全、快速且有效的治疗选择。
研究设计与样本
- 前瞻性研究,25例患者(男/女=9/16,中位年龄76岁,范围61-84岁)共26个肝细胞癌结节(中位直径4.0 cm,范围3.2-5.5 cm),2013年至2018年间行25次射频消融治疗,消融后30-40天通过CT或MRI评估疗效。
诊断标准与关键数值
- 完全消融率100%(26/26个结节);中位随访30个月时局部肿瘤进展5/26个结节(19.2%);4年总生存率49%。
临床应用与阅片要点
- 对不可切除的3.1-6.0 cm肝细胞癌结节,可采用多电极切换系统射频消融,消融后30-40天通过CT或MRI评估完全消融情况。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study was to prospectively evaluate the safety and effectiveness of radiofrequency ablation (RFA) by using a multiple-electrode switching system to treat unresectable medium-large (3.1-6.0 cm) HCC nodules.
METHODS: RFA using a multiple-electrode switching system was performed for HCC nodules with size > 3.0 < 6.0 cm in nonsurgical candidates. Two electrodes were consecutively placed for 3.1-4.0 cm tumours, and three electrodes for 4.1-5.9 cm tumours, with a 2.0-2.5 cm spacing. The power was switched from one electrode to the next automatically when the impedance reached 30 Ω above the baseline level. 25 patients (M/F = 9/16; median age 76 years, range 61-84) with liver cirrhosis (20 HCV-positive) in Child's Class A (22 cases) and B (3 cases) and 26 HCC nodules (median diameter 4.0 cm; range 3.2-5.5 cm) underwent treatment in 25 sessions from 2013 and 2018. Therapeutic effectiveness was assessed through CT or MRI exam at 30-40 days post-ablation.
RESULTS: No procedure-related death or major complications occurred. Complete ablation was obtained in all nodules (100%). At a median follow up of 30 months, local tumor progression occurred in five out of 26 nodules (19.2%). Overall survival at 4 years was 49%.
CONCLUSION: RFA with a multiple-electrode switching system may be a safe, quick and effective therapeutic option for treatment of 3.1- 6.0 cm unresectable HCC tumours.
ADVANCES IN KNOWLEDGE: RFA with multiple electrodes provides favourable clinical results in patients with medium-large HCC nodules who are not suitable for surgery.
引用
- Francica G, Altiero M, Laccetti E, et al. Long-term follow-up of unresectable medium-large hepatocellular carcinoma nodules treated with radiofrequency ablation using a multiple-electrode switching system. Br J Radiol. 2018. PMID: 30272482. doi:10.1259/bjr.20180625
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。